Search Results - "Noker, P. E."

Refine Results
  1. 1

    Pharmacokinetics of Perfluorooctanoate in Cynomolgus Monkeys by Butenhoff, J. L., Kennedy, G. L., Hinderliter, P. M., Lieder, P. H., Jung, R., Hansen, K. J., Gorman, G. S., Noker, P. E., Thomford, P. J.

    Published in Toxicological sciences (01-12-2004)
    “…The pharmacokinetics of perfluorooctanoate (PFOA) in cynomolgus monkeys were studied in a six-month oral capsule dosing study of ammonium perfluorooctanoate…”
    Get full text
    Journal Article
  2. 2

    Toxicity of methylsulfonylmethane in rats by Horváth, K, Noker, P.E, Somfai-Relle, S, Glávits, R, Financsek, I, Schauss, A.G

    Published in Food and chemical toxicology (01-10-2002)
    “…Methylsulfonylmethane (MSM) is a popular dietary supplement used in a variety of conditions including pain, inflammation, allergies, arthritis, parasitic…”
    Get full text
    Journal Article
  3. 3

    Purine nucleoside phosphorylase inhibitors: biochemical and pharmacological studies with 9-benzyl-9-deazaguanine and related compounds by Bennett, Jr, L L, Allan, P W, Noker, P E, Rose, L M, Niwas, S, Montgomery, J A, Erion, M D

    “…Certain derivatives of 9-deazaguanine that contain arylmethyl, heteroarylmethyl or cycloalkylmethyl groups at the 9-position are potent inhibitors of purine…”
    Get more information
    Journal Article
  4. 4

    Antimitotic agents: structure-activity studies with some pyridine derivatives by Temple, Carroll, Rener, Gregory A, Waud, William R, Noker, Patricia E

    Published in Journal of medicinal chemistry (01-10-1992)
    “…Antitumor activity in mice was observed for the oxime of the previously reported ethyl [6-amino-4-[(1-methyl-2-phenyl-2-oxoethyl)amino]-5-nitropyridin -2-yl]…”
    Get full text
    Journal Article
  5. 5

    Role of Hepatic Tetrahydrofolate in the Species Difference in Methanol Toxicity by Black, Kurt A., Eells, Janis T., Noker, Patricia E., Hawtrey, Catherine A., Tephly, Thomas R.

    “…The susceptibility of various species to methanol toxicity is inversely related to the rate of tetrahydrofolate (H4folate)-dependent formate oxidation to…”
    Get full text
    Journal Article
  6. 6

    Diversity of penetration of anti-cancer agents into solid tumours by Simpson-Herren, L, Noker, P E

    Published in Cell proliferation (01-07-1991)
    “…Failure of anti-cancer agents to reach all clonogenic cells at cytotoxic concentrations is recognized as an important form of resistance in solid tumours…”
    Get more information
    Journal Article
  7. 7

    Variability of tumor response to chemotherapy. II: Contribution of tumor heterogeneity by SIMPSON-HERREN, L, NOKER, P. E, WAGONER, S. D

    Published in Cancer chemotherapy and pharmacology (01-08-1988)
    “…The role of tumor-to-tumor variability in response to chemotherapy was investigated in mice bearing mammary adenocarcinoma 16/C treated with melphalan…”
    Get full text
    Journal Article
  8. 8

    Distribution of adriamycin in mice bearing mammary adenocarcinoma 16/C by Simpson-Herren, L, Noker, P E

    Published in Cell proliferation (01-05-1991)
    “…The response of solid mammary adenocarcinoma 16/C to treatment with Adriamycin is highly variable and ranges from growth under treatment to complete…”
    Get more information
    Journal Article
  9. 9

    Methanol poisoning and formate oxidation in nitrous oxide-treated rats by Eells, J T, Makar, A B, Noker, P E, Tephly, T R

    “…Formic acid does not accumulate in the rat after the administration of methanol as it does in methanol-poisoned humans and monkeys. In addition, rats do not…”
    Get more information
    Journal Article
  10. 10

    Variability of tumor response to chemotherapy. I: Contribution of host heterogeneity by SIMPSON-HERREN, L, NOKER, P. E, WAGONER, S. D

    Published in Cancer chemotherapy and pharmacology (01-12-1987)
    “…Host factors that might be associated with the variable response of tumors to effective chemotherapy were studied in B6C3F1 mice bearing transplanted mammary…”
    Get full text
    Journal Article
  11. 11

    Dose-related doxorubicin effect in an orthotopic secondary lung cancer screen by Cowen, M E, Howard, R B, Noker, P E, Zeligman, B E, Mulvin, D W, Marcell, T, Johnston, M R

    Published in The Journal of surgical research (01-04-1994)
    “…Lung cancer is the leading cause of cancer-related death of both sexes in the United States and promises to be a major problem in the world community for…”
    Get more information
    Journal Article
  12. 12

    Secondary screening system for preclinical testing of human lung cancer therapies by Mulvin, D W, Howard, R B, Mitchell, D H, Noker, P E, Kruse, C A, Chu, H D, Bunn, P A, Johnston, M R

    “…The National Cancer Institute has instituted a primary screening system for testing new agents against cultured cancer cell lines. The purpose of this study…”
    Get more information
    Journal Article
  13. 13

    A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans by Olsen, Geary W, Chang, Shu-Ching, Noker, Patricia E, Gorman, Gregory S, Ehresman, David J, Lieder, Paul H, Butenhoff, John L

    Published in Toxicology (Amsterdam) (04-02-2009)
    “…Abstract Materials derived from perfluorobutanesulfonyl fluoride (PBSF, C4 F9 SO2 F) have been introduced as replacements for eight-carbon homolog products…”
    Get full text
    Journal Article
  14. 14

    Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice by Noker, P E, Hill, D L, Kalin, J R, Temple, Jr, C G, Montgomery, J A

    Published in Drug metabolism and disposition (01-11-1985)
    “…The disposition of two 1-deaza-7,8-dihydropteridines, NSC 269416 and NSC 350386, was studied in mice dosed iv. After dosing with 25 mg/kg of NSC 269416, serum…”
    Get more information
    Journal Article
  15. 15

    Disposition of sucrose octa-isobutyrate in rats, dogs and monkeys by Noker, P E, Kalin, J R, McCarthy, D J, el Dareer, S M, Chappel, C I

    Published in Food and chemical toxicology (01-12-1986)
    “…The disposition of 200 mg/kg of 14C-labelled sucrose octa-isobutyrate (14C-SOIB), a component of sucrose acetate isobutyrate (SAIB), a beverage emulsion…”
    Get more information
    Journal Article
  16. 16

    Methanol toxicity: treatment with folic acid and 5-formyl tetrahydrofolic acid by Noker, P E, Eells, J T, Tephly, T R

    “…After methanol administration to monkeys, an accumulation of formate in blood occurs coincident with the development of metabolic acidosis and a depletion of…”
    Get more information
    Journal Article
  17. 17

    Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors by Noker, P E, Simpson-Herren, L, Wagoner, S D

    Published in Cancer chemotherapy and pharmacology (01-01-1987)
    “…Using the triphenylmethane dye, lissamine green, as an indicator of blood perfusion, we have demonstrated that L-phenylalanine mustard (L-PAM) is…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Distribution of clomesone in mice by Noker, P E, Hill, D L

    Published in Cancer treatment reports (01-12-1987)
    “…The distribution of the novel alkylating agent clomesone [2-chloroethyl (methylsulfonyl)-methane sulfonate] has been studied in mice after iv administration of…”
    Get more information
    Journal Article
  20. 20

    Metabolism of 14C-labelled sucrose esters of stearic acid in rats by Noker, P.E., Lin, T.-H., Hill, D.L., Shigeoka, T.

    Published in Food and chemical toxicology (01-06-1997)
    “…Rats were dosed by oral gavage (250 mg/kg) with compounds containing sucrose esterified in four, six or eight positions with stearic acid. For each compound,…”
    Get full text
    Journal Article